Scalar Gauge Management LLC Purchases 66,707 Shares of Cellebrite DI Ltd. (NASDAQ:CLBT)

Scalar Gauge Management LLC grew its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 21.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 383,917 shares of the company’s stock after purchasing an additional 66,707 shares during the period. Cellebrite DI comprises about 3.9% of Scalar Gauge Management LLC’s holdings, making the stock its 11th largest holding. Scalar Gauge Management LLC owned approximately 0.19% of Cellebrite DI worth $8,458,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CLBT. Alliancebernstein L.P. lifted its stake in Cellebrite DI by 109.7% in the fourth quarter. Alliancebernstein L.P. now owns 28,633 shares of the company’s stock worth $631,000 after purchasing an additional 14,981 shares during the last quarter. Pertento Partners LLP increased its holdings in shares of Cellebrite DI by 26.7% in the fourth quarter. Pertento Partners LLP now owns 2,975,374 shares of the company’s stock worth $65,547,000 after buying an additional 626,373 shares during the period. Pictet Asset Management Holding SA bought a new stake in shares of Cellebrite DI in the 4th quarter valued at about $283,000. Blair William & Co. IL boosted its holdings in Cellebrite DI by 15.7% during the 4th quarter. Blair William & Co. IL now owns 143,476 shares of the company’s stock valued at $3,161,000 after acquiring an additional 19,433 shares during the period. Finally, LPL Financial LLC grew its position in Cellebrite DI by 39.0% during the 4th quarter. LPL Financial LLC now owns 54,402 shares of the company’s stock worth $1,198,000 after acquiring an additional 15,267 shares during the last quarter. 45.88% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Lake Street Capital raised their price target on shares of Cellebrite DI from $17.00 to $26.00 and gave the stock a “buy” rating in a report on Friday, February 14th. Needham & Company LLC restated a “buy” rating and set a $28.00 price target on shares of Cellebrite DI in a report on Thursday. Finally, JPMorgan Chase & Co. increased their price objective on Cellebrite DI from $24.00 to $28.00 and gave the stock an “overweight” rating in a report on Tuesday, February 11th. Seven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, Cellebrite DI has a consensus rating of “Buy” and a consensus price target of $23.43.

Cellebrite DI Trading Down 0.8 %

Shares of CLBT opened at $19.46 on Monday. Cellebrite DI Ltd. has a 12 month low of $10.25 and a 12 month high of $26.30. The business’s fifty day simple moving average is $20.85 and its two-hundred day simple moving average is $19.91. The company has a market cap of $4.66 billion, a price-to-earnings ratio of -14.00, a P/E/G ratio of 4.27 and a beta of 1.52.

Cellebrite DI (NASDAQ:CLBT) last released its quarterly earnings data on Thursday, February 13th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. As a group, research analysts forecast that Cellebrite DI Ltd. will post 0.3 EPS for the current year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.